Home › Colite ulcerosa › California
Studi clinici su Colite ulcerosa nello stato di California
40 studi su Colite ulcerosa cercano partecipanti presso sedi nello stato di California.
Città nello stato di California
- San Diego15 studi
- Los Angeles13 studi
- Lancaster8 studi
- Mountain View8 studi
- Anaheim7 studi
- Westminster5 studi
- San Francisco4 studi
- Victorville4 studi
- Thousand Oaks3 studi
- Oxnard3 studi
- Murrieta3 studi
- Newport Beach3 studi
- Folsom3 studi
- San Bernardino3 studi
- Garden Grove3 studi
- Sacramento3 studi
- Chula Vista3 studi
- Orange3 studi
Testo ufficiale dello studio (inglese)
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Clinnova Research /ID# 280509, Anaheim
- Southern California Res. Ctr /ID# 280476, Coronado
- Gastro Care Institute /ID# 281071, Lancaster
- e altri 2
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology and Liver Institute, Escondido
- United Clinical Research Institute, Murrieta
In reclutamentoFase 4
Età da 18 a 80 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Rady Children's Hospital /ID# 271873, San Diego
- University of California San Francisco - Mission Bay /ID# 273022, San Francisco
In reclutamentoFase 3
Età da 2 a 17 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07071519A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Erick Alayo Medical Corp/Gastro SB Clinic, Chula Vista
- Southern California GI and Liver Centers (SCLC), Coronado
- Valley View Research, Garden Grove
- e altri 6
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Palo Alto
In reclutamentoFase 1/2Volontari sani benvenuti
Età da 18 a 75 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 024, Canoga Park
- Site 023, La Jolla
- Site 012, Lancaster
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-018, San Diego
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Clinnova Research ( Site 1042), Anaheim
- Southern California Research Center ( Site 1044), Coronado
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Gastro Care Institute, Lancaster
- Medical Associates Research Group, Inc., San Diego
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- Southern California Research Center, Coronado
- Om Research LLC, Lancaster
- e altri 7
In reclutamentoFase 3
Età 12 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07196748A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Loma Linda University Health System, Loma Linda
- Cedars-Sinai Medical Center, Los Angeles
- Lucile Packard Children's Hospital, Palo Alto
- e altri 1
In reclutamentoFase 2/3
Età da 2 a 17 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- e altri 1
In reclutamentoFase 3
Età da 18 a 70 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- UCSF Medical Center at Mission Bay, San Francisco
In reclutamentoFase 3
Età da 2 a 19 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT04844606LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Clinnova Research - Anaheim, Anaheim
- Om Research LLC, Lancaster
- Biopharma Informatic, LLC, Los Angeles
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- GMC Clinical Research, Folsom
- Om Research LLC, Temple City
- e altri 1
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Cedars-Sinai Medical Center, Los Angeles
- Hoag Hospital Newport Beach, Newport Beach
In reclutamentoFase 4
Età da 18 a 65 · Tutti i sessi · Aggiornato il 21 set 2026 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado
- United Medical Doctors CA - Site Number: 8400044, Murrieta
- Om Research, LLC - Victorville - Site Number: 8400022, Victorville
In reclutamentoFase 3
Età da 16 a 80 · Tutti i sessi · Aggiornato il 15 set 2026 · NCT07185009A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- Gastro SB Clinic, Chula Vista
- United Medical Doctors, Los Alamitos
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 ago 2026 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- FOMAT - Unio Specialty Care Arcadia - Site Number: 8400027, Arcadia
- Alliance Research Institute - Site Number: 8400008, Canoga Park
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado
- e altri 13
In reclutamentoFase 3
Età da 16 a 80 · Tutti i sessi · Aggiornato il 20 ago 2026 · NCT07184996Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
- Vanda Investigational Site, Chula Vista
In reclutamentoFase 3
Età da 18 a 75 · Tutti i sessi · Aggiornato il 18 ago 2026 · NCT07686081Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation
- Cedars Sinai Medical Center, Los Angeles
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 12 ago 2026 · NCT07034443Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Hoag Hospital, Irvine
- UC San Diego Health, La Jolla
- Cedars-Sinai, Los Angeles
- e altri 1
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 7 ago 2026 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Gastroenterology Medical Clinic (Objective Health), Folsom
- Center for Colorectal Innovation, Los Angeles
- Hoag Hospital, Newport Beach
- e altri 1
In reclutamento
Età da 18 a 85 · Tutti i sessi · Aggiornato il 6 ago 2026 · NCT06571669A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital Of Orange County, Orange
In reclutamentoFase 3
Età da 2 a 17 · Tutti i sessi · Aggiornato il 3 ago 2026 · NCT06100289An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Scripps Clinic Torrey Pines, La Jolla
- United Medical Doctors, Los Alamitos
- United Medical Doctors, Los Alamitos
In reclutamentoStudio osservazionale
Età da 18 a 64 · Tutti i sessi · Aggiornato il 9 lug 2026 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Valley View Wellness Medical Center, Garden Grove
- Loma Linda Children's Hospital, Loma Linda
- Loma Linda University Clinical Trial Center, Loma Linda
- e altri 7
In reclutamentoFase 2
Età da 12 a 17 · Tutti i sessi · Aggiornato il 8 lug 2026 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Loma Linda University, Loma Linda
- Children's Hospital of Orange County, Orange
- Stanford Children's Health, Palo Alto
In reclutamentoFase 3
Età da 2 a 17 · Tutti i sessi · Aggiornato il 22 giu 2026 · NCT06405087R-3750 in Patients With Mild to Moderate Ulcerative Colitis
- Amicis Research Center, Valencia
In reclutamentoFase 1
Età da 18 a 65 · Tutti i sessi · Aggiornato il 12 giu 2026 · NCT05666960The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
- Children's Hospital Los Angeles, Los Angeles
In reclutamentoFase 2
Età da 7 a 21 · Tutti i sessi · Aggiornato il 4 giu 2026 · NCT05218850A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Rady Children's Hospital - San Diego - PIN, San Diego
In reclutamentoFase 3
Età 2 e oltre · Tutti i sessi · Aggiornato il 7 mag 2026 · NCT05442567A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400009, Escondido
- Investigational Site Number: 8400006, Lancaster
- Investigational Site Number: 8400025, Thousand Oaks
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 23 apr 2026 · NCT06975722Fermented Food-Supplemented Diet in Ulcerative Colitis
- Stanford University, Palo Alto
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 feb 2026 · NCT04401605The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
- Stanford University, Palo Alto
In reclutamento
Età da 18 a 70 · Tutti i sessi · Aggiornato il 27 feb 2026 · NCT03615690Impact of Prebiotics in Ulcerative Colitis
- UCLA, Los Angeles
In reclutamento
Età da 18 a 85 · Tutti i sessi · Aggiornato il 27 feb 2026 · NCT06495658Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Los Angeles Health, Los Angeles
In reclutamento
Età da 18 a 85 · Tutti i sessi · Aggiornato il 8 gen 2026 · NCT05987852Effects of Pomegranate Juice on Ulcerative Colitis
- West Los Angeles VA Medical Center, Los Angeles
- UCLA Center for Human Nutrition, Los Angeles
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 dic 2025 · NCT07115862Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 008, Garden Grove
In reclutamentoFase 4
Età da 5 a 17 · Tutti i sessi · Aggiornato il 16 set 2025 · NCT04314375Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
- University of California San Diego, La Jolla
In reclutamentoFase 2
Età da 18 a 80 · Tutti i sessi · Aggiornato il 16 mag 2023 · NCT04721873Fonte: ClinicalTrials.gov, dati recuperati il 2 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.